NEW YORK (GenomeWeb) – NanoCellect Biomedical, a developer of microfluidic cell sorting technologies, announced today that it has completed a $10 million Series B financing round, including convertible notes.

The financing included the participation of existing investors FusionX Ventures and Agilent Technologies, in addition to new investors Illumina Ventures, Anzu Partners, Vertical Venture Partners, and 5 Prime Ventures.    

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.